D.J. St. Germain’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.27K Hold
162
﹤0.01% 804
2025
Q4
$1.82K Buy
162
+159
+5,300% +$1.82K ﹤0.01% 816
2025
Q3
$35 Hold
3
﹤0.01% 885
2025
Q2
$37 Hold
3
﹤0.01% 865
2025
Q1
$43 Sell
3
-119
-98% -$1.86K ﹤0.01% 788
2024
Q4
$1.94K Buy
122
+119
+3,967% +$2.35K ﹤0.01% 736
2024
Q3
$72 Hold
3
﹤0.01% 756
2024
Q2
$60 Hold
3
﹤0.01% 761
2024
Q1
$60 Hold
3
﹤0.01% 769
2023
Q4
$67 Hold
3
﹤0.01% 768
2023
Q3
$61 Hold
3
﹤0.01% 742
2023
Q2
$77 Buy
+3
New +$79 ﹤0.01% 713

Other funds holding AVNS

D.J. St. Germain's AVNS Position: Q1 2026 in Review

D.J. St. Germain held its Avanos Medical (AVNS) position steady in Q1 2026 at 162 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #804.

D.J. St. Germain first reported a position in AVNS in Q2 2023 and has held it in 12 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • D.J. St. Germain held 162 shares of Avanos Medical worth $2.27K as of Q1 2026.
  • D.J. St. Germain left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of D.J. St. Germain's portfolio in Q1 2026, its #804 holding.
  • D.J. St. Germain first reported a position in Avanos Medical in Q2 2023 and has held it in 12 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.